VIVO Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: Meridian Bioscience, Inc.

SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience

3 years ago - By: Benzinga - Mentions: DV

DoubleVerify To Join S&P SmallCap 600 On January 31

3 years ago - By: Benzinga

Meridian Bioscience's Return On Capital Employed Overview

3 years ago - By: Meridian Bioscience, Inc.

Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger

3 years ago - By: BusinessInsider

MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2022 OPERATING RESULTS

3 years ago - By: Investor's Business Daily - Mentions: SILK LNTH RMD

Silk Road Medical Stock Scores Relative Strength Rating Upgrade

3 years ago - By: Investor's Business Daily - Mentions: PEN BSX

Penumbra Stock Hits 80-Plus Relative Strength Rating Benchmark

3 years ago - By: Seeking Alpha

Meridian Bioscience Non-GAAP EPS of $0.21, revenue of $65.67M (NASDAQ:VIVO)

3 years ago - By: The Motley Fool - Mentions: GOOG VRTX LLY

4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire

3 years ago - By: BusinessInsider

MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS

3 years ago - By: Meridian Bioscience, Inc.

MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS

3 years ago - By: Meridian Bioscience, Inc.

Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular Assay

3 years ago - By: Investor's Business Daily - Mentions: SILK LNTH RGEN

Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating

3 years ago - By: Meridian Bioscience, Inc.

Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction

3 years ago - By: Kahn Swick & Foti, LLC

MERIDIAN BIOSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Meridian Bioscience, Inc. - VIVO

3 years ago - By: Weiss Law

SHAREHOLDER ALERT: Weiss Law Investigates Meridian Bioscience, Inc.

3 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Meridian Bioscience, Inc. has obtained a Fair Price in its transaction with the Consortium

3 years ago - By: InvestorPlace - Mentions: AMC ANVS GME

Dear AMC Stock Fans, Mark Your Calendars for Aug. 4

3 years ago - By: InvestorPlace

MERIDIAN BIOSCIENCE INC (VIVO) Stock News

VIVO Latest News, Press Relases and Analysis

SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience

DoubleVerify To Join S&P SmallCap 600 On January 31

Meridian Bioscience's Return On Capital Employed Overview

Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger

MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2022 OPERATING RESULTS

Silk Road Medical Stock Scores Relative Strength Rating Upgrade

Penumbra Stock Hits 80-Plus Relative Strength Rating Benchmark

Meridian Bioscience Non-GAAP EPS of $0.21, revenue of $65.67M (NASDAQ:VIVO)

4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire

MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS

MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS

Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular Assay

Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating

Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction

MERIDIAN BIOSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Meridian Bioscience, Inc. - VIVO

SHAREHOLDER ALERT: Weiss Law Investigates Meridian Bioscience, Inc.

Shareholder Alert: Ademi LLP investigates whether Meridian Bioscience, Inc. has obtained a Fair Price in its transaction with the Consortium

Dear AMC Stock Fans, Mark Your Calendars for Aug. 4

Meridian Biosciences (VIVO) Stock Trending on $1.5 Billion Buyout Agreement